The analysis presented is based on a current price of $18.97.Until this past year, the EPS has been growing since 2002. Even using the more conservative 2001-2008 time period, the compounded annual growth (CAGR) has been 53%. Although the company has… More
Ceradyne has grown nicely over the past decade. It remains a popular pick (current CAPS 5-star). I plan on keeping my eye on it over the next year, as I have some optimism that the business is in good shape to out-perform longer-term if management… More